Veracyte [VCYT] vs Danaher [DHR] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 21 vital metrics comparison: Veracyte Inc. wins in 6 metrics, Danaher Corporation wins in 14 metrics, with 0 ties. Danaher Corporation appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Veracyte Inc. | Danaher Corporation | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 40.43 | 34.61 | Danaher Corporation |
| Price-to-Book Ratio | 2.01 | 2.40 | Veracyte Inc. |
| Debt-to-Equity Ratio | 3.03 | 37.17 | Veracyte Inc. |
| PEG Ratio | 0.06 | 3.84 | Veracyte Inc. |
| EV/EBITDA | 26.79 | 17.69 | Danaher Corporation |
| Profit Margin (TTM) | 12.83% | 14.89% | Danaher Corporation |
| Operating Margin (TTM) | 17.50% | 22.94% | Danaher Corporation |
| EBITDA Margin (TTM) | 17.50% | 22.94% | Danaher Corporation |
| Return on Equity | 5.34% | 7.08% | Danaher Corporation |
| Return on Assets (TTM) | 2.91% | 4.19% | Danaher Corporation |
| Free Cash Flow (TTM) | $126.63M | $5.26B | Danaher Corporation |
| Dividend Yield | N/A | 0.56% | N/A |
| 1-Year Return | 74.15% | -3.81% | Veracyte Inc. |
| Price-to-Sales Ratio (TTM) | 5.11 | 5.10 | Danaher Corporation |
| Enterprise Value | $2.26B | $140.38B | Danaher Corporation |
| EV/Revenue Ratio | 4.37 | 5.67 | Veracyte Inc. |
| Gross Profit Margin (TTM) | 72.51% | 60.34% | Veracyte Inc. |
| Revenue per Share (TTM) | $7 | $35 | Danaher Corporation |
| Earnings per Share (Diluted) | $0.82 | $5.16 | Danaher Corporation |
| Beta (Stock Volatility) | 1.96 | 0.99 | Danaher Corporation |
| Short % of Float | 8.87% | 1.10% | Danaher Corporation |
Veracyte Inc. vs Danaher Corporation Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Veracyte Inc. | 1.88% | 9.46% | 45.59% | 38.83% | 1.99% | 14.89% |
| Danaher Corporation | 1.12% | 2.86% | 2.32% | -12.71% | -22.05% | -22.71% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Veracyte Inc. | 74.15% | 73.43% | 40.68% | 774.34% | 276.75% | 276.75% |
| Danaher Corporation | -3.81% | -12.18% | -14.95% | 176.52% | 423.71% | 744.91% |
Performance & Financial Health Analysis: Veracyte Inc. vs Danaher Corporation
| Metric | VCYT | DHR |
|---|---|---|
| Market Information | ||
| Market Cap | $2.74B | $126.39B |
| Market Cap Category | Mid cap | Large cap |
| 10 Day Avg. Volume | 744,389 | 5,174,666 |
| 90 Day Avg. Volume | 891,963 | 4,357,215 |
| Last Close | $48.70 | $178.08 |
| 52 Week Range | $22.61 - $50.71 | $160.93 - $242.80 |
| % from 52W High | -3.96% | -26.66% |
| All-Time High | $86.03 (Feb 08, 2021) | $296.06 (Sep 06, 2021) |
| % from All-Time High | -43.39% | -39.85% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.19% | 0.04% |
| Quarterly Earnings Growth | 7.05% | 0.08% |
| Financial Health | ||
| Profit Margin (TTM) | 0.13% | 0.15% |
| Operating Margin (TTM) | 0.18% | 0.23% |
| Return on Equity (TTM) | 0.05% | 0.07% |
| Debt to Equity (MRQ) | 3.03 | 37.17 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $16.50 | $74.32 |
| Cash per Share (MRQ) | $5.20 | $8.06 |
| Operating Cash Flow (TTM) | $136.31M | $6.44B |
| Levered Free Cash Flow (TTM) | $86.80M | $4.57B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.56% |
| Last 12-Month Dividend | N/A | $1.28 |
Valuation & Enterprise Metrics Analysis: Veracyte Inc. vs Danaher Corporation
| Metric | VCYT (Apr 26, 2026) | DHR (Apr 24, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 40.43 | 34.61 |
| Forward P/E | 18.80 | 19.64 |
| PEG Ratio | 0.06 | 3.84 |
| Price to Sales (TTM) | 5.11 | 5.10 |
| Price to Book (MRQ) | 2.01 | 2.40 |
| Market Capitalization | ||
| Market Capitalization | $2.74B | $126.39B |
| Enterprise Value | $2.26B | $140.38B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 4.37 | 5.67 |
| Enterprise to EBITDA | 26.79 | 17.69 |
| Risk & Other Metrics | ||
| Beta | 1.96 | 0.99 |
| Book Value per Share (MRQ) | $16.50 | $74.32 |
Financial Statements Comparison: Veracyte Inc. vs Danaher Corporation
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | VCYT (2025) | DHR (2025) |
|---|---|---|
| Revenue/Sales | 517.15M | 24.57B |
| Cost of Goods Sold | 154.61M | 10.05B |
| COGS % of Revenue | 29.9% | 40.9% |
| Gross Profit | 362.53M | 14.52B |
| Gross Margin | 70.1% | 59.1% |
| Research & Development | 70.81M | 1.60B |
| Operating Income (EBIT) | 78.28M | 4.69B |
| Operating Margin | 15.1% | 19.1% |
| EBITDA | 112.86M | 7.17B |
| EBITDA Margin | 21.8% | 29.2% |
| Pre-Tax Income | 68.20M | 4.23B |
| Pre-Tax Income % of Revenue | 13.2% | 17.2% |
| Income Tax | 1.85M | 633.00M |
| Income Tax % of Revenue | 0.4% | 2.6% |
| Net Income (Profit) | 66.35M | 3.61B |
| Profit Margin | 12.8% | 14.7% |
Balance Sheet & Liquidity Metrics
| Metric | VCYT (2025) | DHR (2025) |
|---|---|---|
| Cash & Equivalents | 362.58M | 4.62B |
| Total Current Assets | 488.38M | 12.76B |
| Total Current Assets % of Revenue | 94.4% | 51.9% |
| Total Current Liabilities | 59.94M | 6.81B |
| Total Current Liabilities % of Revenue | 11.6% | 27.7% |
| Long-Term Debt | 35.60M | 19.50B |
| Long-Term Debt % of Revenue | 6.9% | 79.4% |
| Total Shareholders Equity | 1.31B | 52.54B |
| Retained Earnings | -377.63M | 46.89B |
| Retained Earnings % of Revenue | -73.0% | 190.9% |
| Property, Plant & Equipment | 73.32M | 2.14B |
Cash Flow Statement Comparison
| Metric | VCYT (2025) | DHR (2025) |
|---|---|---|
| Operating Cash Flow | 111.92M | 5.64B |
| Operating Cash Flow % of Revenue | 21.6% | 23.0% |
| Capital Expenditures | -9.68M | -1.12B |
| Free Cash Flow | 126.63M | 5.26B |
| FCF Margin | 24.5% | 21.4% |
| Debt Repayment | N/A | -500.00M |
| Common Stock Repurchase | N/A | -3.09B |
Short Interest & Institutional Ownership Analysis
| Metric | VCYT | DHR |
|---|---|---|
| Shares Short | 6.33M | 6.94M |
| Short Ratio | 5.89 | 1.68 |
| Short % of Float | 8.87% | 1.10% |
| Shares Outstanding | 79.36M | 707.70M |
| Float Shares | 79.02M | 630.65M |
| % Held by Insiders | 1.00% | 10.78% |
| % Held by Institutions | 110.26% | 85.08% |
| % Held by Public | -11.26% | 4.14% |
Dividend Analysis & Yield Comparison: Veracyte Inc. vs Danaher Corporation
| Metric | VCYT | DHR |
|---|---|---|
| Last 12-Month Dividend | N/A | $1.28 |
| Last 12-Month Dividend Yield | N/A | 0.56% |
| 3-Year Avg Annual Dividend | N/A | $10.51 |
| 3-Year Avg Dividend Yield | N/A | 1.11% |
| 3-Year Total Dividends | N/A | $31.54 |
| Ex-Dividend Date | N/A | Dec 26, 2025 |